Table 2.
Quartiles of Dietary Iron Intake, ORs (95% CI) | |||||
---|---|---|---|---|---|
Q1 | Q2 | Q3 | Q4 | p-Value for Trend 1 | |
Total Iron Intake (mg/day) | <12.72 | (12.72–16.50) | (16.50–21.88) | ≥21.88 | |
n | 776 | 773 | 776 | 774 | |
Metabolic syndrome | |||||
Crude model | Reference | 1.12(0.88,1.42) | 1.24(0.98,1.57) | 1.17(0.92,1.48) | 0.335 |
Adjusted model 2 | Reference | 1.37(1.06,1.78) * | 1.47(1.11,1.94) ** | 1.59(1.15,2.20) ** | 0.022 |
p-Value for interaction 3 = 0.060 | |||||
Metabolic syndrome components | |||||
Elevated blood pressure | |||||
Crude model | Reference | 0.95(0.79,1.13) | 1.19(1.00,1.42) * | 1.07(0.89,1.27) | 0.063 |
Adjusted model 2 | Reference | 1.14(0.92,1.41) | 1.33(1.06,1.66) * | 1.21(0.93,1.57) | 0.100 |
Elevated waist circumference | |||||
Crude model | Reference | 1.07(0.89,1.29) | 1.09(0.91,1.32) | 1.00(0.83,1.21) | 0.691 |
Adjusted model 2 | Reference | 1.25(1.01,1.53) * | 1.29(1.04,1.60) * | 1.25(0.96,1.61) | 0.096 |
Elevated fasting glucose | |||||
Crude model | Reference | 1.03(0.83,1.27) | 1.16(0.94,1.42) | 1.12(0.91,1.38) | 0.458 |
Adjusted model 2 | Reference | 1.18(0.94,1.49) | 1.25(0.98,1.60) | 1.33(1.00,1.77) | 0.221 |
Elevated triglycerides | |||||
Crude model | Reference | 1.17(0.95,1.43) | 1.46(1.20,1.77) ** | 1.34(1.10,1.64) ** | 0.001 |
Adjusted model 2 | Reference | 1.14(0.92,1.42) | 1.37(1.09,1.72) ** | 1.31(1.00,1.71) * | 0.047 |
Reduced HDL-C 4 | |||||
Crude model | Reference | 1.09(0.86,1.38) | 1.11(0.87,1.41) | 0.91(0.71,1.16) | 0.348 |
Adjusted model 2 | Reference | 1.27(0.98,1.65) | 1.42(1.08,1.87) * | 1.31(0.94,1.83) | 0.088 |
* p < 0.05, ** p < 0.001. 1 The p-value for the trend was examined using the medians in each quartile of dietary iron intake. 2 The models were adjusted for age, sex, income, physical activity level, intentional physical exercise, smoking status, alcohol use and dietary total energy intake. 3 The p-value for the interaction was tested for the quartiles of dietary iron intake by gender. 4 HDL-C: high-density lipoprotein-cholesterol.